CClinicalTrials.gg
TerminatedNCT03163134Updated Aug 16, 2017Results posted

Lumbar Drain After Endoscopic Surgery of the Skull Base

An interventional study of Lumbar Drain in Quality of Life, sponsored by University of Pittsburgh. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-08-16.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Prevention

Why this study was terminated
Due to the fact data results were statistically significant among the two groups

From the registry’s dates

  • Registered 6 years 3 months after the study started (first participant enrolled Feb 2011, registered May 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The overall purpose of this study was to assess the necessity of lumbar drain placement after endoscopic endonasal approach (EEA) surgery in reducing cerebrospinal fluid (CSF) leak postoperatively and promote a standardization of its use.

Read the detailed description

In the past, reconstructions were performed using fat grafts or fascia lata for EEA surgery. Considerably high postoperative CSF leaks were reported and were a major cause of concern due CSF fistula increasing risk of infection. Since external lumbar drain can lower CSF pressure and is believed to prevent post operative CSF leak, it was used commonly after EEA. With improvements in EEA skull base reconstructions using a nasal septal flap in the recent years, postoperative CSF leaks have been reported in much lower rates. With this improvement in reconstruction techniques, the use of lumbar drain may not be necessary as it may not significantly lower the risk of CSF leak further. In this prospective randomized study, we will randomize subjects at high risk for CSF leak to either receive a prophylactic lumbar drain or to not receive a prophylactic lumbar drain and compare the rate of CSF leaks and other complications in the two groups.

02

Conditions studied

  • Quality of Life

Keywords

  • Lumbar Drain, CSF Leak
03

In context

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age or older
  • Patients undergoing EEA for resection of brain tumors
  • Dural defect greater than 1cm
  • Extensive arachnoid dissection
  • Dissection into a ventricle or cistern

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years of age
  • Spina Bifida
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
170 participants (actual)

Study arms

  • No intervention
    No Lumbar Drain Group

    Group of patients that did not receive a lumbar drain after surgery

  • Experimental
    Lumbar Drain Group

    Group of patients that received a lumbar drain after surgery

    Device: Lumbar Drain

Interventions

  • DeviceLumbar Drain
06

What researchers measure

Primary outcomes

  1. Number of Participants With Cerebrospinal Fluid (CSF) Leak

    Determine the rate of CSF leak in endoscopic endonasal approach (EEA) patients who received lumbar drain placement and EEA patients who did not receive lumbar drain placement.

    Time frame: 1month

Secondary outcomes

  1. Number of Participants With Postoperative Complications

    Determine the rate of any postoperative complications related to Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Meningitis and Respiratory infections in EEA patients who received lumbar drain placement and EEA patients who did not receive lumbar drain placement.

    Time frame: 1 year

07

Results

Posted Aug 16, 2017

Participant flow

All adult patients undergoing endoscopic endonasal approach (EEA) at the Center for Cranial Base Surgery of the University of Pittsburgh Medical Center from February 2011 to April 2015 were evaluated for enrollment.

Participant flow — Overall Study
MilestoneNo Lumbar Drain GroupLumbar Drain Group
Started8585
Completed8585
Not completed00

Outcome measures

PrimaryNumber of Participants With Cerebrospinal Fluid (CSF) Leak

Determine the rate of CSF leak in endoscopic endonasal approach (EEA) patients who received lumbar drain placement and EEA patients who did not receive lumbar drain placement.

Time frame:
1month
Reported as:
Count of participants · Participants
Number of Participants With Cerebrospinal Fluid (CSF) Leak
ParticipantsNo Lumbar Drain GroupLumbar Drain Group
Number of Participants With Cerebrospinal Fluid (CSF) Leak187
Statistical analysis
  • No Lumbar Drain Group vs Lumbar Drain Group · Chi-squared · p = 0.017
SecondaryNumber of Participants With Postoperative Complications

Determine the rate of any postoperative complications related to Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Meningitis and Respiratory infections in EEA patients who received lumbar drain placement and EEA patients who did not receive lumbar drain placement.

Time frame:
1 year
Reported as:
Count of participants · Participants
Number of Participants With Postoperative Complications
ParticipantsNo Lumbar Drain GroupLumbar Drain Group
Number of Participants With Postoperative Complications1720
Statistical analysis
  • No Lumbar Drain Group vs Lumbar Drain Group · Chi-squared · p = 0.577

Adverse events

Collected over Three times a year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
No Lumbar Drain Group0/85 (0%)0/85 (0%)0/85 (0%)
Lumbar Drain Group0/85 (0%)0/85 (0%)0/85 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)No Lumbar Drain GroupLumbar Drain GroupTotal
Mean52 ± 15.1151 ± 15.4952 ± 15.30
Sex: Female, Male
Sex: Female, Male(Participants)No Lumbar Drain GroupLumbar Drain GroupTotal
Female4956105
Male362965
Region of Enrollment
Region of Enrollment(Participants)No Lumbar Drain GroupLumbar Drain GroupTotal
United States8585170
08

Study locations

1 site
  • University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213, United States
09

References and documents

Publications

  • Zwagerman NT, Wang EW, Shin SS, Chang YF, Fernandez-Miranda JC, Snyderman CH, Gardner PA. Does lumbar drainage reduce postoperative cerebrospinal fluid leak after endoscopic endonasal skull base surgery? A prospective, randomized controlled trial. J Neurosurg. 2018 Oct 19;131(4):1172-1178. doi: 10.3171/2018.4.JNS172447. Print 2019 Oct 1. PubMed 30485224 ↗

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03163134
Lead sponsor
University of Pittsburgh
Responsible party
Paul Gardner (Associate Professor, University of Pittsburgh) — Principal investigator
First posted
May 22, 2017
Start date
Feb 3, 2011
Primary completion
Apr 27, 2015
Completion
Apr 27, 2015
Results posted
Aug 16, 2017
Last update
Aug 16, 2017

Study contacts

Paul Gardner, MD
principal investigator · University of Pittsburgh Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion